Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Instituto Nacional de Cancerologia de Mexico
Seventy-three eligible patients were randomized. Thirty-nine patients received WBI (30 Gy in 10 fractions over 2 weeks) concomitant with 150 mg of CLQ for 4 weeks (the CLQ group). Thirty-four patients received the same schedule of WBI concomitant with a placebo for 4 weeks (the control arm). All the patients were evaluated for quality of life (QoL) using the EORTC QLQ-C30 questionnaire (Mexican version) before beginning radiotherapy and one month later.
Age
46–61
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 to 80 years of age
At leat one brain metastasis MRI
KPS 70 or more
RTOG-RPA I or II
Basic Laboratory requirements
You may not be if
Candidates for radiosurgery, neurosurgery
Patients treated with radiotherapy before entered to the study
